Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessChallenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia
Predicting the response to medical therapy and subsequently individualizing the treatment to increase efficacy or reduce toxicity has been a longstanding clinical goal. Not least within oncology, where many pa...
-
Article
Relating genomic variation to drug response in childhood acute lymphoblastic leukemia by multiplexed targeted sequencing